CD8A and type 1 diabetes mellitus: CD4+, but not CD8+ T‐cell proliferation, was significantly inhibited by BL001‐treated M1 derived from T1D individuals, indicating that BL001 reprogramming of M1 partly inhibits T‐cell proliferation (Figure 4J,K).